Ebcay, Roseta F.

HRN: 27-50-71  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2025
CEFTAZIDIME 1GM (VIAL)
07/21/2025
07/27/2025
IV
2 Grams
Q 8 Hours
Ptb
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: